Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: Kidney Int. 2013 Jun 5;84(6):1166–1175. doi: 10.1038/ki.2013.209

Table 4.

Infiltrating Monocytes/Macrophages in WT vs. PAI-1−/− Mice at Day 14 after UUO

Treatment WT PAI-1−/−
Control 2.75±0.41 2.54±0.38
Tβ4+POPi 2.51±0.36 2.85±0.18
Tβ4 2.78±0.27 2.36±0.07
Ac-SDKP 1.74±0.13* 0.98±0.11 *,

Abbreviations: POPi, POP inhibitor; Tβ4+POPi, thymosin β4 plus POP inhibitor; Tβ4, thymosin β4.

Data are given as percentage of F4/80 positive area, mean ± SEM, n=5–8 in each group.

*

p<0.05 vs. its own control

p<0.05 for WT vs. PAI-1−/− mice with same treatment.